[Ended]The 7th CHD-Indonesia teleconference

Ver 1.4

Local Time At Main Venue

2018/04/23 (Mon) 10:30-60min, Kanagawa,JP (UTC+09:00)

Organizer

Toshihide Asou

Contents

Pediatrics

Topics

Aortic Arch Reconstruction in Neonates and Small Infants Associated with Complex Congenital Heart Disease

The development of deep hypothermic circulatory arrest (DHCA) in 1960s was a breakthrough of pediatric cardiac surgery that allowed us to perform corrective surgeries of many lesions previously not amenable to repair, such as arch obstruction including interruprion of aortic arch, coarctation of the aorta, and hypoplastic left heart syndrome in neonates. Neurologic injury, however, became a well-documented consequence of DHCA by 1970s. Since then, enormous efforts have been pursued to eliminate neurologic complications. In 1996, a unique technique, selective cerebral perfusion, was reported to avoid circulatory arrest and perform antegrade cerebral perfusion during aortic arch repair in neonates and small infants. Since then, the antegrade perfusion technique during aortic arch reconstruction has been widely used among pediatric cardiac surgeons. In the 7th CHD Indonesia-Japan teleconference, we would present our own technique and its outcome of aortic arch repair for aortic obstruction in neonates and infants.

Connection Method

Vidyo

Style

Conference

Server At

Kyushu University

Chairs

Chair

Toshihide Asou
National Cardiovascular Center Harapan Kita / ID

Chief Engineer1

Motoyoshi Kawataki
Kanagawa Children's Medical Center / JP

Chief Engineer2

Yoshiko Houkabe
Kyushu University Hospital / JP

Participating Institutions

Note: The institution shown in red is not confirmed.

City, Country

Institution

Moderator

Schedule

Precautions

• The conference will be recorded by the photos and movies.

• Pictures taken at the conference may be published in TEMDEC home page, annual report and conference presentations.

• Do not present the personal information of patients any in oral and presentation materials without obtaining the patient’s consent.

* For more information, please refer to the TEMDEC policy.